$LECT Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading in Axogen, Inc..

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview

Overview of all insider trading transactions in Axogen, Inc.. Get notifications about new insider transactions in Axogen, Inc. for free.

Page: < prev 1 2 3 4 5 next >

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Dec 31 2018	LECT	AxoGen, Inc.	DeVinney Erick Wayne	VP, Clinical&Transl ...	Option Exercise	A	0.00	3,000	0	3,000
Dec 31 2018	LECT	AxoGen, Inc.	DeVinney Erick Wayne	VP, Clinical&Transl ...	Option Exercise	A	19.17	11,900	228,123	11,900
Dec 31 2018	LECT	AxoGen, Inc.	Hansen David K	VP Finance & Treasu ...	Option Exercise	A	0.00	200	0	200
Dec 31 2018	LECT	AxoGen, Inc.	Hansen David K	VP Finance & Treasu ...	Option Exercise	A	19.17	800	15,336	800
Dec 21 2018	LECT	AxoGen, Inc.	Zaderej Karen L.	CEO	Option Exercise	M	2.74	30,000	82,200	0
Dec 21 2018	LECT	AxoGen, Inc.	Zaderej Karen L.	CEO	Buy	M	2.74	30,000	82,200	476,209	446.2 K to 476.2 K (+6.72 %)
Dec 04 2018	LECT	AxoGen, Inc.	Freitag Gregory Gene	General Counsel	Sell	S	33.00	45,000	1,485,000	95,865	140.9 K to 95.9 K (-31.95 %)
Nov 21 2018	LECT	AxoGen, Inc.	Zaderej Karen L.	CEO	Option Exercise	M	2.74	70,000	191,800	0
Nov 21 2018	LECT	AxoGen, Inc.	Zaderej Karen L.	CEO	Payment of Exercise	F	28.37	6,761	191,810	446,209	453 K to 446.2 K (-1.49 %)
Nov 21 2018	LECT	AxoGen, Inc.	Zaderej Karen L.	CEO	Buy	M	2.74	70,000	191,800	452,970	383 K to 453 K (+18.28 %)
Nov 15 2018	LECT	AxoGen, Inc.	DeVinney Erick Wayne	VP, Clinical&Transl ...	Option Exercise	M	0.27	274	74	0
Nov 15 2018	LECT	AxoGen, Inc.	DeVinney Erick Wayne	VP, Clinical&Transl ...	Option Exercise	M	2.74	35,000	95,900	0
Nov 15 2018	LECT	AxoGen, Inc.	DeVinney Erick Wayne	VP, Clinical&Transl ...	Buy	M	0.27	274	74	37,410	37.1 K to 37.4 K (+0.74 %)
Nov 15 2018	LECT	AxoGen, Inc.	DeVinney Erick Wayne	VP, Clinical&Transl ...	Payment of Exercise	F	33.28	2,882	95,913	37,136	40 K to 37.1 K (-7.20 %)
Nov 15 2018	LECT	AxoGen, Inc.	DeVinney Erick Wayne	VP, Clinical&Transl ...	Buy	M	2.74	35,000	95,900	40,018	5 K to 40 K (+697.49 %)
Nov 15 2018	LECT	AxoGen, Inc.	Freitag Gregory Gene	General Counsel	Sell	S	32.25	20,000	645,000	140,865	160.9 K to 140.9 K (-12.43 %)
Nov 15 2018	LECT	AxoGen, Inc.	Zaderej Karen L.	CEO	Sell	S	32.93	12,000	395,160	382,970	395 K to 383 K (-3.04 %)
Nov 15 2018	LECT	AxoGen, Inc.	Zaderej Karen L.	CEO	Sell	S	33.42	13,000	434,460	394,970	408 K to 395 K (-3.19 %)
Nov 05 2018	LECT	AxoGen, Inc.	MARTINEZ MARIA D.	Chief Human Resourc ...	Option Exercise	A	38.25	40,000	1,530,000	40,000
Nov 05 2018	LECT	AxoGen, Inc.	Billet Isabelle	Chief Strategy and ...	Option Exercise	A	38.25	40,000	1,530,000	40,000
Oct 03 2018	LECT	AxoGen, Inc.	Gold Mark Stephen	Director	Gift	G	0.00	20,000	0	344,761	364.8 K to 344.8 K (-5.48 %)
Sep 24 2018	LECT	AxoGen, Inc.	Grooms Jamie Mark	Director	Option Exercise	M	2.75	12,000	33,000	0
Sep 24 2018	LECT	AxoGen, Inc.	Grooms Jamie Mark	Director	Option Exercise	M	0.27	494	133	0
Sep 24 2018	LECT	AxoGen, Inc.	Grooms Jamie Mark	Director	Buy	M	2.75	12,000	33,000	18,693	6.7 K to 18.7 K (+179.29 %)
Sep 24 2018	LECT	AxoGen, Inc.	Grooms Jamie Mark	Director	Buy	M	0.27	494	133	6,693	6.2 K to 6.7 K (+7.97 %)
Sep 05 2018	LECT	AxoGen, Inc.	Scopelianos Angelo	VP Research & Devel ...	Option Exercise	A	45.00	40,000	1,800,000	40,000
Aug 16 2018	LECT	AxoGen, Inc.	Wendell Amy McBride	Director	Buy	P	36.89	5,000	184,450	18,333	13.3 K to 18.3 K (+37.50 %)
Aug 13 2018	LECT	AxoGen, Inc.	Gold Mark Stephen	Director	Gift	G	0.00	30,487	0	344,761	375.2 K to 344.8 K (-8.12 %)
Aug 09 2018	LECT	AxoGen, Inc.	MCCARREY SHAWN F	SVP Sales	Option Exercise	M	3.67	55,000	201,850	13,000
Aug 09 2018	LECT	AxoGen, Inc.	MCCARREY SHAWN F	SVP Sales	Payment of Exercise	F	39.30	5,136	201,845	82,921	88.1 K to 82.9 K (-5.83 %)
Aug 09 2018	LECT	AxoGen, Inc.	MCCARREY SHAWN F	SVP Sales	Buy	M	3.67	55,000	201,850	88,057	33.1 K to 88.1 K (+166.38 %)
Aug 09 2018	LECT	AxoGen, Inc.	Zaderej Karen L.	CEO	Payment of Exercise	F	39.30	10,060	395,358	407,970	418 K to 408 K (-2.41 %)
Aug 06 2018	LECT	AxoGen, Inc.	Zaderej Karen L.	CEO	Option Exercise	M	2.74	175,000	479,500	100,000
Aug 06 2018	LECT	AxoGen, Inc.	Zaderej Karen L.	CEO	Buy	M	2.74	175,000	479,500	418,030	243 K to 418 K (+72.01 %)
Jul 11 2018	LECT	AxoGen, Inc.	COLLERAN LISA N	Director	Option Exercise	A	53.65	3,916	210,093	3,916
Jul 11 2018	LECT	AxoGen, Inc.	COLLERAN LISA N	Director	Option Exercise	A	53.65	9,134	490,039	9,134
Jun 12 2018	LECT	AxoGen, Inc.	Rudelius Robert James	Director	Option Exercise	M	2.75	12,000	33,000	0
Jun 12 2018	LECT	AxoGen, Inc.	Rudelius Robert James	Director	Payment of Exercise	F	48.40	682	33,009	34,591	35.3 K to 34.6 K (-1.93 %)
Jun 12 2018	LECT	AxoGen, Inc.	Rudelius Robert James	Director	Buy	M	2.75	12,000	33,000	35,273	23.3 K to 35.3 K (+51.56 %)
Jun 05 2018	LECT	AxoGen, Inc.	Wendell Amy McBride	Director	Option Exercise	A	49.65	4,780	237,327	4,780
Jun 05 2018	LECT	AxoGen, Inc.	Grooms Jamie Mark	Director	Option Exercise	A	49.65	4,780	237,327	4,780
Jun 05 2018	LECT	AxoGen, Inc.	Gold Mark Stephen	Director	Option Exercise	A	49.65	4,780	237,327	4,780
Jun 05 2018	LECT	AxoGen, Inc.	Gold Mark Stephen	Director	Option Exercise	M	14.85	15,000	222,750	0
Jun 05 2018	LECT	AxoGen, Inc.	Gold Mark Stephen	Director	Buy	M	14.85	15,000	222,750	375,248	360.2 K to 375.2 K (+4.16 %)
Jun 05 2018	LECT	AxoGen, Inc.	NEELS GUIDO J	Director	Option Exercise	A	49.65	4,780	237,327	4,780
Jun 05 2018	LECT	AxoGen, Inc.	Rudelius Robert James	Director	Option Exercise	A	49.65	4,780	237,327	4,780
May 18 2018	LECT	AxoGen, Inc.	MCCARREY SHAWN F	SVP Sales	Sell	S	43.47	10,000	434,700	33,057	43.1 K to 33.1 K (-23.23 %)
Mar 27 2018	LECT	AxoGen, Inc.	Donovan Michael Patrick	VP Operations	Option Exercise	M	2.74	35,000	95,900	5,000
Mar 27 2018	LECT	AxoGen, Inc.	Donovan Michael Patrick	VP Operations	Payment of Exercise	F	40.25	2,042	82,191	37,617	39.7 K to 37.6 K (-5.15 %)
Mar 27 2018	LECT	AxoGen, Inc.	Donovan Michael Patrick	VP Operations	Buy	M	2.74	30,000	82,200	39,659	9.7 K to 39.7 K (+310.59 %)
Mar 26 2018	LECT	AxoGen, Inc.	Hansen David K	VP Finance & Treasu ...	Option Exercise	M	2.75	1,500	4,125	0
Mar 26 2018	LECT	AxoGen, Inc.	Hansen David K	VP Finance & Treasu ...	Option Exercise	M	2.74	35,000	95,900	0
Mar 26 2018	LECT	AxoGen, Inc.	Hansen David K	VP Finance & Treasu ...	Payment of Exercise	F	39.55	104	4,113	43,792	43.9 K to 43.8 K (-0.24 %)
Mar 26 2018	LECT	AxoGen, Inc.	Hansen David K	VP Finance & Treasu ...	Buy	M	2.75	1,500	4,125	43,896	42.4 K to 43.9 K (+3.54 %)
Mar 26 2018	LECT	AxoGen, Inc.	Hansen David K	VP Finance & Treasu ...	Payment of Exercise	F	39.55	2,425	95,909	42,396	44.8 K to 42.4 K (-5.41 %)
Mar 26 2018	LECT	AxoGen, Inc.	Hansen David K	VP Finance & Treasu ...	Buy	M	2.74	35,000	95,900	44,821	9.8 K to 44.8 K (+356.38 %)
Mar 23 2018	LECT	AxoGen, Inc.	Freitag Gregory Gene	General Counsel & S ...	Option Exercise	M	4.81	15,000	72,150	0
Mar 23 2018	LECT	AxoGen, Inc.	Freitag Gregory Gene	General Counsel & S ...	Option Exercise	M	2.46	16,000	39,360	0
Mar 23 2018	LECT	AxoGen, Inc.	Freitag Gregory Gene	General Counsel & S ...	Payment of Exercise	F	38.50	1,874	72,149	160,865	162.7 K to 160.9 K (-1.15 %)
Mar 23 2018	LECT	AxoGen, Inc.	Freitag Gregory Gene	General Counsel & S ...	Buy	M	4.81	15,000	72,150	162,739	147.7 K to 162.7 K (+10.15 %)
Mar 23 2018	LECT	AxoGen, Inc.	Freitag Gregory Gene	General Counsel & S ...	Payment of Exercise	F	38.50	1,022	39,347	147,739	148.8 K to 147.7 K (-0.69 %)
Mar 23 2018	LECT	AxoGen, Inc.	Freitag Gregory Gene	General Counsel & S ...	Buy	M	2.46	16,000	39,360	148,761	132.8 K to 148.8 K (+12.05 %)
Feb 23 2018	LECT	AxoGen, Inc.	Grooms Jamie Mark	Director	Sell	S	28.40	57,406	1,630,330	372	57.8 K to 372 (-99.36 %)
Feb 20 2018	LECT	AxoGen, Inc.	Grooms Jamie Mark	Director	Sell	S	27.90	36,740	1,025,046	62,861	99.6 K to 62.9 K (-36.89 %)
Feb 20 2018	LECT	AxoGen, Inc.	Grooms Jamie Mark	Director	Sell	S	27.35	26,655	729,014	99,601	126.3 K to 99.6 K (-21.11 %)
Feb 20 2018	LECT	AxoGen, Inc.	MCCARREY SHAWN F	SVP Sales	Payment of Exercise	F	27.40	3,260	89,324	43,057	46.3 K to 43.1 K (-7.04 %)
Feb 20 2018	LECT	AxoGen, Inc.	MCCARREY SHAWN F	SVP Sales	Grant	A	0.00	7,150	0	46,317	39.2 K to 46.3 K (+18.26 %)
Feb 15 2018	LECT	AxoGen, Inc.	Grooms Jamie Mark	VP, CFO	Sell	S	27.11	43,403	1,176,655	126,256	169.7 K to 126.3 K (-25.58 %)
Feb 15 2018	LECT	AxoGen, Inc.	Grooms Jamie Mark	VP, CFO	Sell	S	26.71	9,073	242,340	0	9.1 K to 0 (-100.00 %)
Feb 15 2018	LECT	AxoGen, Inc.	Grooms Jamie Mark	VP, CFO	Sell	S	26.72	32,936	880,050	169,659	202.6 K to 169.7 K (-16.26 %)
Feb 15 2018	LECT	AxoGen, Inc.	Grooms Jamie Mark	VP, CFO	Sell	S	26.22	3,200	83,904	9,073	12.3 K to 9.1 K (-26.07 %)
Feb 15 2018	LECT	AxoGen, Inc.	Grooms Jamie Mark	VP, CFO	Sell	S	26.20	7,100	186,020	202,595	209.7 K to 202.6 K (-3.39 %)
Dec 20 2017	LECT	AxoGen, Inc.	Freitag Gregory Gene	General Counsel & S ...	Option Exercise	A	0.00	3,700	0	3,700
Dec 20 2017	LECT	AxoGen, Inc.	Freitag Gregory Gene	General Counsel & S ...	Option Exercise	A	27.00	22,100	596,700	22,100
Dec 20 2017	LECT	AxoGen, Inc.	Hansen David K	Chief Accounting Of ...	Option Exercise	A	0.00	1,500	0	1,500
Dec 20 2017	LECT	AxoGen, Inc.	Hansen David K	Chief Accounting Of ...	Option Exercise	A	27.00	8,600	232,200	8,600
Dec 20 2017	LECT	AxoGen, Inc.	Donovan Michael Patrick	VP Operations	Option Exercise	A	0.00	1,500	0	1,500
Dec 20 2017	LECT	AxoGen, Inc.	Donovan Michael Patrick	VP Operations	Option Exercise	A	27.00	9,000	243,000	9,000
Dec 20 2017	LECT	AxoGen, Inc.	DeVinney Erick Wayne	VP, Clinical&Transl ...	Option Exercise	A	0.00	2,300	0	2,300
Dec 20 2017	LECT	AxoGen, Inc.	DeVinney Erick Wayne	VP, Clinical&Transl ...	Option Exercise	A	27.00	13,900	375,300	13,900
Dec 20 2017	LECT	AxoGen, Inc.	Friedman Mark Louis	VP,Regulatory & Qua ...	Option Exercise	A	0.00	1,500	0	1,500
Dec 20 2017	LECT	AxoGen, Inc.	Friedman Mark Louis	VP,Regulatory & Qua ...	Option Exercise	A	27.00	9,000	243,000	9,000
Dec 20 2017	LECT	AxoGen, Inc.	Leach Kevin	Vice President Mark ...	Option Exercise	A	0.00	1,400	0	1,400
Dec 20 2017	LECT	AxoGen, Inc.	Leach Kevin	Vice President Mark ...	Option Exercise	A	27.00	8,250	222,750	8,250
Dec 20 2017	LECT	AxoGen, Inc.	MCCARREY SHAWN F	SVP Sales	Option Exercise	A	0.00	1,500	0	1,500
Dec 20 2017	LECT	AxoGen, Inc.	MCCARREY SHAWN F	SVP Sales	Option Exercise	A	27.00	9,000	243,000	9,000
Dec 20 2017	LECT	AxoGen, Inc.	Gingrich Jon S.	Chief Commercial Of ...	Option Exercise	A	0.00	5,500	0	5,500
Dec 20 2017	LECT	AxoGen, Inc.	Gingrich Jon S.	Chief Commercial Of ...	Option Exercise	A	27.00	32,600	880,200	32,600
Dec 20 2017	LECT	AxoGen, Inc.	MARIANI PETER J	Chief Financial Off ...	Option Exercise	A	0.00	7,600	0	7,600
Dec 20 2017	LECT	AxoGen, Inc.	MARIANI PETER J	Chief Financial Off ...	Option Exercise	A	27.00	45,000	1,215,000	45,000
Dec 20 2017	LECT	AxoGen, Inc.	Zaderej Karen L.	CEO	Option Exercise	A	0.00	12,500	0	12,500
Dec 20 2017	LECT	AxoGen, Inc.	Zaderej Karen L.	CEO	Option Exercise	A	27.00	75,000	2,025,000	75,000
Dec 13 2017	LECT	AxoGen, Inc.	Grooms Jamie Mark	Director	Sell	S	26.34	16,585	436,849	240,607	257.2 K to 240.6 K (-6.45 %)
Dec 13 2017	LECT	AxoGen, Inc.	Grooms Jamie Mark	Director	Sell	S	26.35	21,820	574,957	257,192	279 K to 257.2 K (-7.82 %)
Dec 08 2017	LECT	AxoGen, Inc.	Grooms Jamie Mark	Director	Sell	S	26.37	31,805	838,698	281,312	313.1 K to 281.3 K (-10.16 %)
Dec 08 2017	LECT	AxoGen, Inc.	Grooms Jamie Mark	Director	Sell	S	26.50	31,200	826,800	313,117	344.3 K to 313.1 K (-9.06 %)
Dec 08 2017	LECT	AxoGen, Inc.	Grooms Jamie Mark	Director	Sell	S	26.22	21,290	558,224	344,317	365.6 K to 344.3 K (-5.82 %)
Nov 21 2017	LECT	AxoGen, Inc.	Essex Woodlands Fund IX, L.P.	10% Owner	Sell	S	19.74	1,150,000	22,701,000	3,711,111	4.9 M to 3.7 M (-23.66 %)
Nov 21 2017	LECT	AxoGen, Inc.	NEELS GUIDO J	Director	Sell	S	19.74	1,150,000	22,701,000	3,371,111	4.5 M to 3.4 M (-25.44 %)
Nov 15 2017	LECT	AxoGen, Inc.	Gold Mark Stephen	Director	Option Exercise	M	5.09	15,000	76,350	0
Nov 15 2017	LECT	AxoGen, Inc.	Gold Mark Stephen	Director	Buy	M	5.09	15,000	76,350	360,248	345.2 K to 360.2 K (+4.34 %)
Nov 03 2017	LECT	AxoGen, Inc.	Grooms Jamie Mark	Director	Option Exercise	M	0.27	3,197	863	0
Nov 03 2017	LECT	AxoGen, Inc.	Grooms Jamie Mark	Director	Option Exercise	M	0.27	11,182	3,019	0
Nov 03 2017	LECT	AxoGen, Inc.	Grooms Jamie Mark	Director	Payment of Exercise	F	20.60	189	3,893	365,607	365.8 K to 365.6 K (-0.05 %)
Nov 03 2017	LECT	AxoGen, Inc.	Grooms Jamie Mark	Director	Buy	M	0.27	14,379	3,882	365,796	351.4 K to 365.8 K (+4.09 %)
Oct 26 2017	LECT	AxoGen, Inc.	Friedman Mark Louis	VP,Regulatory & Qua ...	Option Exercise	M	1.07	16,829	18,007	0
Oct 26 2017	LECT	AxoGen, Inc.	Friedman Mark Louis	VP,Regulatory & Qua ...	Option Exercise	M	4.81	4,375	21,044	625
Oct 26 2017	LECT	AxoGen, Inc.	Friedman Mark Louis	VP,Regulatory & Qua ...	Option Exercise	M	3.67	5,313	19,499	3,187
Oct 26 2017	LECT	AxoGen, Inc.	Friedman Mark Louis	VP,Regulatory & Qua ...	Option Exercise	M	5.45	1,250	6,813	3,750
Oct 26 2017	LECT	AxoGen, Inc.	Friedman Mark Louis	VP,Regulatory & Qua ...	Option Exercise	M	2.74	40,000	109,600	0
Oct 26 2017	LECT	AxoGen, Inc.	Friedman Mark Louis	VP,Regulatory & Qua ...	Buy	M	1.07	16,829	18,007	67,952	51.1 K to 68 K (+32.92 %)
Oct 26 2017	LECT	AxoGen, Inc.	Friedman Mark Louis	VP,Regulatory & Qua ...	Buy	M	4.81	4,375	21,044	51,123	46.7 K to 51.1 K (+9.36 %)
Oct 26 2017	LECT	AxoGen, Inc.	Friedman Mark Louis	VP,Regulatory & Qua ...	Buy	M	3.67	5,313	19,499	46,748	41.4 K to 46.7 K (+12.82 %)
Oct 26 2017	LECT	AxoGen, Inc.	Friedman Mark Louis	VP,Regulatory & Qua ...	Buy	M	5.45	1,250	6,813	41,435	40.2 K to 41.4 K (+3.11 %)
Oct 26 2017	LECT	AxoGen, Inc.	Friedman Mark Louis	VP,Regulatory & Qua ...	Payment of Exercise	F	20.00	5,480	109,600	40,185	45.7 K to 40.2 K (-12.00 %)
Oct 26 2017	LECT	AxoGen, Inc.	Friedman Mark Louis	VP,Regulatory & Qua ...	Buy	M	2.74	40,000	109,600	45,665	5.7 K to 45.7 K (+706.09 %)
Sep 27 2017	LECT	AxoGen, Inc.	Freitag Gregory Gene	General Counsel & S ...	Option Exercise	M	2.74	10,000	27,400	36,000
Sep 27 2017	LECT	AxoGen, Inc.	Freitag Gregory Gene	General Counsel & S ...	Payment of Exercise	F	18.90	1,450	27,405	99,666	101.1 K to 99.7 K (-1.43 %)
Sep 27 2017	LECT	AxoGen, Inc.	Freitag Gregory Gene	General Counsel & S ...	Buy	M	2.74	10,000	27,400	101,116	91.1 K to 101.1 K (+10.98 %)
Sep 12 2017	LECT	AxoGen, Inc.	Rudelius Robert James	Director	Option Exercise	M	3.50	20,000	70,000	0
Sep 12 2017	LECT	AxoGen, Inc.	Rudelius Robert James	Director	Sell	S	18.00	16,143	290,574	23,273	39.4 K to 23.3 K (-40.96 %)
Sep 12 2017	LECT	AxoGen, Inc.	Rudelius Robert James	Director	Payment of Exercise	F	18.15	3,857	70,005	39,416	43.3 K to 39.4 K (-8.91 %)
Sep 12 2017	LECT	AxoGen, Inc.	Rudelius Robert James	Director	Buy	M	3.50	20,000	70,000	43,273	23.3 K to 43.3 K (+85.94 %)
Aug 29 2017	LECT	AxoGen, Inc.	Freitag Gregory Gene	General Counsel & S ...	Option Exercise	M	2.74	23,000	63,020	46,000
Aug 29 2017	LECT	AxoGen, Inc.	Freitag Gregory Gene	General Counsel & S ...	Payment of Exercise	F	16.65	3,785	63,020	91,116	94.9 K to 91.1 K (-3.99 %)
Aug 29 2017	LECT	AxoGen, Inc.	Freitag Gregory Gene	General Counsel & S ...	Buy	M	2.74	23,000	63,020	94,901	71.9 K to 94.9 K (+31.99 %)
Aug 04 2017	LECT	AxoGen, Inc.	MCCARREY SHAWN F	SVP Sales	Payment of Exercise	F	15.15	2,383	36,102	39,167	41.6 K to 39.2 K (-5.74 %)
Aug 04 2017	LECT	AxoGen, Inc.	MCCARREY SHAWN F	SVP Sales	Grant	A	0.00	7,150	0	41,550	34.4 K to 41.6 K (+20.78 %)
Jul 18 2017	LECT	AxoGen, Inc.	Gingrich Jon S.	Chief Commercial Of ...	Option Exercise	A	16.85	115,000	1,937,750	115,000
Jun 08 2017	LECT	AxoGen, Inc.	NEELS GUIDO J	Director	Option Exercise	A	14.85	15,000	222,750	15,000
Jun 05 2017	LECT	AxoGen, Inc.	Wendell Amy McBride	Director	Option Exercise	A	14.85	15,000	222,750	15,000
Jun 05 2017	LECT	AxoGen, Inc.	Rudelius Robert James	Director	Option Exercise	A	14.85	15,000	222,750	15,000
Jun 05 2017	LECT	AxoGen, Inc.	Gold Mark Stephen	Director	Option Exercise	A	14.85	15,000	222,750	15,000
Jun 05 2017	LECT	AxoGen, Inc.	Grooms Jamie Mark	Director	Option Exercise	A	14.85	15,000	222,750	15,000
Jun 01 2017	LECT	AxoGen, Inc.	Gold Mark Stephen	Director	Option Exercise	M	8.95	5,000	44,750	0
Jun 01 2017	LECT	AxoGen, Inc.	Gold Mark Stephen	Director	Buy	M	8.95	5,000	44,750	345,248	340.2 K to 345.2 K (+1.47 %)
May 26 2017	LECT	AxoGen, Inc.	Gold Mark Stephen	Director	Option Exercise	M	4.81	15,000	72,150	0
May 26 2017	LECT	AxoGen, Inc.	Gold Mark Stephen	Director	Buy	M	4.81	15,000	72,150	340,248	325.2 K to 340.2 K (+4.61 %)
Mar 14 2017	LECT	AxoGen, Inc.	DeVinney Erick Wayne	VP, Clinical&Transl ...	Option Exercise	M	0.27	359	97	0
Mar 14 2017	LECT	AxoGen, Inc.	DeVinney Erick Wayne	VP, Clinical&Transl ...	Option Exercise	M	0.27	4,659	1,258	0
Mar 14 2017	LECT	AxoGen, Inc.	DeVinney Erick Wayne	VP, Clinical&Transl ...	Buy	M	0.27	359	97	5,018	4.7 K to 5 K (+7.71 %)
Mar 14 2017	LECT	AxoGen, Inc.	DeVinney Erick Wayne	VP, Clinical&Transl ...	Buy	M	0.27	4,659	1,258	4,659	0 to 4.7 K
Mar 14 2017	LECT	AxoGen, Inc.	Donovan Michael Patrick	VP Operations	Option Exercise	M	2.74	5,000	13,700	30,000
Mar 14 2017	LECT	AxoGen, Inc.	Donovan Michael Patrick	VP Operations	Option Exercise	M	0.27	4,659	1,258	0
Mar 14 2017	LECT	AxoGen, Inc.	Donovan Michael Patrick	VP Operations	Buy	M	2.74	5,000	13,700	9,659	4.7 K to 9.7 K (+107.32 %)
Mar 14 2017	LECT	AxoGen, Inc.	Donovan Michael Patrick	VP Operations	Buy	M	0.27	4,659	1,258	4,659	0 to 4.7 K
Mar 14 2017	LECT	AxoGen, Inc.	Freitag Gregory Gene	General Counsel & S ...	Option Exercise	M	2.74	23,000	63,020	69,000
Mar 14 2017	LECT	AxoGen, Inc.	Freitag Gregory Gene	General Counsel & S ...	Buy	M	2.74	23,000	63,020	71,901	48.9 K to 71.9 K (+47.03 %)
Jan 03 2017	LECT	AxoGen, Inc.	Zaderej Karen L.	CEO	Option Exercise	A	8.95	209,500	1,875,025	209,500
Jan 03 2017	LECT	AxoGen, Inc.	Zaderej Karen L.	CEO	Grant	A	0.00	40,000	0	282,147	242.1 K to 282.1 K (+16.52 %)

Page: < prev 1 2 3 4 5 next >